reconstitution protocol FAQ

Discard the vial immediately. Do not inject cloudy or particulate-containing solution. Incomplete dissolution indicates the lyophilised powder was compromised before you opened it (temperature excursion during shipping or manufacturing defect) or that you introduced too much mechanical agitation during mixing. Contact your supplier with the lot number and request replacement; reputable peptide manufacturers track temperature during shipping and will replace vials that arrived outside specification.

Discard the vial immediately. Cloudiness indicates either bacterial contamination or peptide aggregation. Both make the solution unsafe for research use. Aggregation occurs when epithalon molecules clump together due to pH drift, temperature stress, or oxidation, forming insoluble particles that cannot be filtered out. Bacterial contamination presents as cloudiness with a faint odour or visible sediment at the vial bottom. Properly reconstituted epithalon should be crystal-clear with no visible particulates under normal room light.

Leave the vial undisturbed at room temperature for an additional 5 minutes, then check again. Persistent cloudiness indicates either peptide aggregation from improper injection technique or contamination from non-sterile water. If the solution does not clear after 10 minutes of passive sitting, do not use it. Aggregated peptides cannot be re-dissolved, and injecting particulate matter into research subjects introduces uncontrolled variables. Cloudy solutions also suggest the powder may have been exposed to heat or moisture before reconstitution, which pre-degrades the peptide. Always source lyophilised peptides from suppliers with documented cold chain protocols.

Assess the duration and temperature. If the vial was unrefrigerated for fewer than 8 hours at temperatures below 25°C, refrigerate it immediately and use it within one week instead of the standard 28 days. Beyond 8 hours or at higher temperatures, oxidation has likely reduced potency by 10–15%. Acceptable for non-critical applications but not for research requiring precise dosing. Temperature excursions above 30°C for any duration warrant disposal.

Use sterile water for injection as a one-time alternative, but reduce the stability window to 7 days maximum. Bacteriostatic water contains 0.9% benzyl alcohol, which inhibits bacterial growth in multi-dose vials. Sterile water lacks this preservative, meaning contamination risk increases with every needle entry. If using sterile water, draw all doses into separate sterile syringes immediately after reconstitution and refrigerate them individually.

Let the vial sit undisturbed for an additional 5 minutes, then swirl again gently. Glutathione dissolves readily in aqueous solution. Persistent residue suggests either incomplete lyophilization during manufacturing or incorrect water volume. If powder remains after 15 minutes total, the vial may be defective. Do not add more water to compensate, as this dilutes your concentration unpredictably. Contact your supplier for a replacement.

If the reconstituted vial sat at room temperature (20–25°C) for less than 30 minutes, refrigerate it immediately and proceed normally. Beyond 60 minutes at room temperature, expect 5–10% potency reduction even after refrigeration. Peptides left unrefrigerated for 4+ hours should be discarded. Bacterial growth begins within 2–3 hours at ambient temperature despite benzyl alcohol, and amino acid oxidation is already measurable at that point.

Discard the vial immediately and do not administer any remaining solution. Cloudiness or precipitate formation indicates peptide aggregation. The thymic extract has lost tertiary structure and is no longer bioactive. This typically results from either bacterial contamination introduced during non-sterile withdrawal or a brief temperature excursion that destabilised the protein. Aggregated peptides can trigger immune reactions at the injection site without providing therapeutic effect. Always use fresh alcohol swabs before every needle insertion into the vial and verify your refrigerator maintains 2–8°C consistently using a calibrated thermometer.

Contact the supplier immediately for a replacement vial and do not use the compromised product. Lyophilised peptides should arrive on dry ice or in insulated packaging with temperature monitors showing continuous sub-zero temperatures throughout transit. A warm vial indicates cold-chain failure. Even brief exposure to room temperature accelerates oxidative degradation in thymic peptides. Our team has tested peptides after shipping temperature excursions using HPLC analysis and found 40–60% reduction in intact peptide content after just 48 hours at 20°C. Reputable suppliers like Real Peptides guarantee cold-chain integrity and will replace compromised shipments without charge.

Move the vial to a more stable location immediately and verify actual shelf temperature with a standalone thermometer. If the excursion lasted less than 2 hours and peak temperature stayed below 15°C, refrigerate immediately and use the solution within 14 days instead of 28. Potency loss accelerates but the peptide isn't necessarily ruined. Temperature spikes above 15°C for more than 4 hours cause irreversible aggregation in most peptides; discard the vial and reconstitute fresh.

Administer the missed dose as soon as you remember and resume your regular schedule from that point forward. Do not double-dose to 'catch up'. Thymalin's mechanism involves gradual thymic reconstitution over weeks, not acute immune activation. A single missed dose in a 20-week protocol has minimal impact on overall T-lymphocyte maturation outcomes. Missing consecutive weeks, however, may reduce protocol efficacy since thymic epithelial support requires sustained peptide presence. If you've missed more than two consecutive scheduled doses, consult your research protocol supervisor before resuming.

Use a purpose-built medical cooler like a FRIO wallet or insulin travel case that maintains 2–8°C for 36–48 hours without electricity. Standard ice packs risk freezing the solution if they contact the vial directly. Freeze damage is as destructive as heat exposure for peptide stability. Never transport reconstituted peptides in checked luggage or without active temperature control.

Discard it immediately. Cloudiness indicates bacterial contamination, protein aggregation, or both. Neither is reversible and neither is safe for research use. Particulate matter means the peptide structure has degraded beyond recovery. Clear reconstituted solution should remain clear throughout the 28-day window when stored correctly. Any visual change is a definitive failure signal.

Use the reconstituted peptide within 7 days and store it under strict aseptic conditions with minimal vial access. Sterile water lacks antimicrobial preservatives, so bacterial contamination risk increases significantly after day 5 even with perfect refrigeration. If the protocol requires dosing beyond 7 days, discard the vial and reconstitute a fresh batch with bacteriostatic water. Attempting to extend sterile-water-reconstituted peptides to 28 days creates unacceptable contamination risk. The visual clarity of the solution does not correlate with bacterial load.

Use a validated cold-chain transport container that maintains 2–8°C for the entire transit duration. Purpose-built peptide transport cases use phase-change refrigerant packs pre-conditioned to 4°C. Not frozen ice packs, which can cause localised sub-zero temperatures that damage peptide structure. Place a calibrated min/max thermometer inside the transport container alongside the vial to verify temperature never exceeded 8°C during transit. Standard household coolers with ice packs are insufficient. Temperature drift in unvalidated coolers routinely exceeds 10°C within 3–4 hours. If validated transport isn't available, transport the lyophilised powder instead and reconstitute at the destination.

Discard the vial. An 8-hour exposure to room temperature (20–25°C) causes 35–50% peptide degradation through thermal aggregation and partial denaturation of the copper complex. The solution will look identical to a properly stored vial. Clear, colorless, no visible precipitate. But bioactivity is compromised. There is no reliable way to test potency without specialized equipment, and using degraded peptide introduces confounding variables into any experimental protocol. The cost of replacing the vial is trivial compared to the cost of unreliable data.

Discard the vial immediately. Cloudiness or particulate matter indicates protein aggregation, bacterial contamination, or chemical degradation. None of these conditions are reversible, and injecting degraded peptide ranges from therapeutically ineffective to potentially harmful depending on the contaminant source. Cloudiness can result from reconstitution shear forces (vigorous shaking), temperature excursions (freeze-thaw or excessive heat), or bacterial growth. Attempting to filter or clarify the solution does not restore peptide integrity.

Refrigerate immediately and use within seven days instead of the full 28-day window. Three hours at room temperature (approximately 22°C) causes measurable but not catastrophic degradation. The peptide retains most of its activity but the stability margin is reduced. Do not extend storage beyond one week after this temperature abuse.

Condensation itself does not harm the peptide, but it creates contamination risk. Condensation on the rubber stopper can trap airborne bacteria and transfer them into the vial during needle puncture. Always wipe condensation off the stopper with a sterile alcohol swab before accessing the vial. Allow the swab to air-dry completely. Puncturing through wet alcohol dilutes the bacteriostatic preservative and introduces liquid contaminants.

Discard immediately. Cloudiness or particulate matter indicates either bacterial contamination or peptide aggregation. Both render the solution unsafe and ineffective for research use. Aggregation occurs when peptide molecules clump together due to temperature abuse, pH shift, or repeated freeze-thaw cycles (which should never occur with properly stored reconstituted peptide). Contamination occurs when septic technique fails during draws or when the vial's sterility is compromised through septum degradation. Never attempt to 'clarify' cloudy peptide solutions by filtering or warming. The underlying cause cannot be reversed.